Cargando…
Pediatric severe asthma: a case series report and perspectives on anti-IgE treatment
BACKGROUND: The primary goal of asthma management is to achieve disease control for reducing the risk of future exacerbations and progressive loss of lung function. Asthma not responding to treatment may result in significant morbidity. In many children with uncontrolled symptoms, the diagnosis of a...
Autores principales: | Mirra, Virginia, Montella, Silvia, Santamaria, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820802/ https://www.ncbi.nlm.nih.gov/pubmed/29466963 http://dx.doi.org/10.1186/s12887-018-1019-9 |
Ejemplares similares
-
Severe asthma: anti-IgE or anti-IL-5?
por: Papathanassiou, Evgenia, et al.
Publicado: (2016) -
Clinical Experience with Anti-IgE Monoclonal Antibody (Omalizumab) in Pediatric Severe Allergic Asthma—A Romanian Perspective
por: Berghea, Elena Camelia, et al.
Publicado: (2021) -
A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma
por: D’Amato, Gennaro, et al.
Publicado: (2007) -
dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies
por: Palomares, Óscar, et al.
Publicado: (2017) -
Anti- IgE treatment in asthma: is atopy essential?
por: Gulec, Mustafa, et al.
Publicado: (2015)